新聞稿

在2019年美国临床肿瘤学大会（ASCO）年会上，公布了关于肿瘤电场治疗（Tumor Treating Fields）的多项研究数据，包括2张壁报和6个线上摘要。今年的ASCO大会于5月31日至6月4日在美国芝加哥举办。

壁报：

Analysis of the EF-14 phase III trial reveals that tumor treating fields alter progression patterns in glioblastoma

摘要编号：2055

Radiological response patterns in the phase 2 STELLAR trial of TTFields with chemotherapy for first-line treatment of malignant pleural mesothelioma (MPM)

摘要编号：8551

线上摘要：

Meta-analysis of toxicity data in thoracic and abdominal malignancies from: Clinical trials in tumor treating fields

摘要编号：e14658

A general approach to optimizing tumor treating fields therapy

摘要编号：e14668

The combined treatment of 150 kHz tumor treating fields (TTFields) and sorafenib inhibits hepatocellular carcinoma in vitro and in vivo

摘要编号：e15653

The combined treatment of 150 kHz tumor treating fields (TTFields) and cisplatin or pemetrexed inhibits mesothelioma cells in vitro and in vivo

摘要编号：e20069

Transducer array layout optimization for the treatment of pancreatic cancer using TumorTreating Fields (TTFields) in the phase 3 PANOVA-3 trial

摘要编号：e15766

Survival meta-analysis from fifteen years of a standard systemic therapy in malignant pleural mesothelioma

摘要编号：e20066